Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
01 1Interquim, S.A.
02 1Evonik Corporation
03 1Ami Lifesciences Private Limited
04 1AURORE PHARMACEUTICALS PRIVATE LIMITED
05 1AX Pharmaceutical Corp
06 1Amoli Organics (A Division of Umedica Laboratories Private Limited)
07 1Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)
08 1Assia Chemical Industries Ltd - Teva Tech Site
09 1Aurobindo Pharma Limited
10 1Azico Biophore India Private Limited
11 1Darmerica
12 1Fagron Inc
13 1Galenova Inc
14 2Glenmark Life Sciences Limited
15 1Honour Lab Limited
16 1Jubilant Pharmova Limited
17 1Kalchem International inc
18 1LETCO MEDICAL, LLC
19 1MEDISCA Inc.
20 1MSN Organics Private Limited
21 1Maithili Life Sciences Private Limited
22 1Pharma Source Direct, Inc.
23 1Professional Compounding Centers of America
24 2SMS Pharmaceuticals Limited
25 1SUN PHARMACEUTICAL INDUSTRIES, INC.
26 1Srini Pharmaceuticals Private Limited
27 1Synergene Active Ingredients Private Limited
28 1Topharman Shandong Co., Ltd.
29 1Unichem Laboratories Limited, India
30 1Willow Birch Pharma, Inc
31 1Xenex Laboratories Inc
32 1Zhejiang Bamboo Pharmaceuticals Co.,Ltd
33 1Zhejiang Huahai Pharmaceutical Co., Ltd.
29
PharmaCompass offers a list of Tadalafil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tadalafil manufacturer or Tadalafil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tadalafil manufacturer or Tadalafil supplier.
PharmaCompass also assists you with knowing the Tadalafil API Price utilized in the formulation of products. Tadalafil API Price is not always fixed or binding as the Tadalafil Price is obtained through a variety of data sources. The Tadalafil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione, including repackagers and relabelers. The FDA regulates (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione supplier is an individual or a company that provides (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione active pharmaceutical ingredient (API) or (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione finished formulations upon request. The (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione suppliers may include (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione API manufacturers, exporters, distributors and traders.
click here to find a list of (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione suppliers with NDC on PharmaCompass.
We have 32 companies offering (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
Get in contact with the supplier of your choice:
